Yayın:
Design, Synthesis, and Biological Evaluation of N,N-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBelgin Sever
dc.contributor.authorHalilibrahim Çiftçi
dc.contributor.orcid0000-0003-4847-9711
dc.date.accessioned2026-05-20T10:19:55Z
dc.date.issued2026-03-04
dc.identifier.doi10.3390/ph19030416
dc.identifier.endpage416
dc.identifier.issn1424-8247
dc.identifier.issue3
dc.identifier.openalexW7133537997
dc.identifier.startpage416
dc.identifier.urihttps://hdl.handle.net/11421/39786
dc.identifier.urihttps://doi.org/10.3390/ph19030416
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofPharmaceuticals
dc.rightsopenAccess
dc.subjectK562 cells
dc.subjectImatinib
dc.subjectABL
dc.subjectTyrosine kinase
dc.subjectMyeloid leukemia
dc.subjectCytotoxicity
dc.subjectADME
dc.subjectAnnexin
dc.subjectPeripheral blood mononuclear cell
dc.subjectBruton's tyrosine kinase
dc.titleDesign, Synthesis, and Biological Evaluation of N,N-Diphenylaniline-Based Derivatives as Antiproliferative Agents and ABL TK Inhibitors Against CML
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications